Latest news & updates
Related information
RSS feed of this pageThis page shows the last 20 updates that have been made to the TGA website and includes product recalls, alerts and media releases/statements issued by the TGA in recent weeks.
The TGA also has a number of email lists to which you can subscribe to receive updates by email.
18 May 2012
PIP breast implants - TGA update
Updated information on safety concerns with PIP breast implants
18 May 2012
Quad (4 X Point) Walking Stick
Medical device recall notice
17 May 2012
Documents released under Section 11C of the Freedom of Information Act 1982
Added FOI 290-1112 documents
17 May 2012
Low value turnover application forms
Updated form for low value turnover declaration for new products
17 May 2012
Quad (4 X Point) Walking Stick
The TGA advises that Endeavour Industries brand Quad (4 X Point) Walking Sticks, Product Code X640, are being recalled
17 May 2012
Riata and Riata ST Silicone cardiac leads - increased wear
The TGA advises of potential problems with Riata & Riata ST Silicone cardiac leads (manufactured by St Jude Medical) for implantable cardiac cardioverter-defibrillators (ICDs)
11 May 2012
PIP breast implants - TGA update
Updated information on safety concerns with PIP breast implants
10 May 2012
ANZTPA Update email list
Email subscription service notifying of news & updates related to ANZTPA or its business to business projects
10 May 2012
Improved search facilities from the eBS website
The TGA has launched an improved interface for the publicly accessible e-Business Services (eBS) website
9 May 2012
Draft compositional guideline: Magnesium citrate - dibasic tetrahydrate
Draft compositional guideine for magnesium citrate dibasic tetrahydrate. Closing date: 22 June 2012
8 May 2012
Australian Public Assessment Reports for prescription medicines (AusPARs)
Added Abatacept (rch), Boceprevir
4 May 2012
PIP breast implants - TGA update
Updated information on safety concerns with PIP breast implants
4 May 2012
Orphan drugs
Added ivacaftor to the list of designated orphan drugs
4 May 2012
Proposed advisory statements for medicines - fexofenadine and loperamide
The TGA is seeking comments from interested parties on the proposed advisory statements for fexofenadine and loperamide. Closing date: 4 June 2012
2 May 2012
Prominent Scientist and Regulator appointed new Head of TGA
Dr John Skerritt has been appointed the new national manager of the TGA
30 April 2012
Prescription medicine BPR update newsletter, April 2012
April 2012 issue of the Prescription Medicines Business Process Review newsletter
30 April 2012
Labelling and packaging review
Update regarding the labelling and packaging review
27 April 2012
Consumer questions & answers - PIP breast implants
Updated questions and answers for consumers about breast implants
27 April 2012
PIP breast implants - TGA update
Updated information on safety concerns with PIP breast implants
26 April 2012
Public submissions on scheduling matters referred to ACCS#4 and ACMS#5 (February 2012)
Additional submissions on scheduling matters for ACCS & ACMS February 2012 meetings
Web page last updated: Monday, 5 December 2011
URL: http://www.tga.gov.au/newsroom/news-latest.htm